Cargando…
Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review
BACKGROUND: Histiocytic sarcoma (HS) is an aggressive malignant neoplasm. HS in the central nervous system is exceptionally rare and associated with a poor prognosis. This report documents a case of primary HS of the central nervous system with treatment including surgery, radiotherapy, and chemothe...
Autores principales: | May, Jackson M., Waddle, Mark R., Miller, Daniel H., Stross, William C., Kaleem, Tasneem A., May, Byron C., Miller, Robert C., Jiang, Liuyan, Strong, Gerald W., Trifiletti, Daniel M., Chaichana, Kaisorn L., Reimer, Ronald, Tun, Han W., Peterson, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126020/ https://www.ncbi.nlm.nih.gov/pubmed/30185195 http://dx.doi.org/10.1186/s13014-018-1115-x |
Ejemplares similares
-
Google Search Trends in Oncology and the Impact of Celebrity Cancer Awareness
por: Kaleem, Tasneem, et al.
Publicado: (2019) -
Application of PD-L1 blockade in refractory histiocytic sarcoma: A case report
por: Imataki, Osamu, et al.
Publicado: (2022) -
PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors
por: Wang, Jaeyun Jane, et al.
Publicado: (2019) -
Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT
por: Chauhan, Kiran, et al.
Publicado: (2023) -
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018)